Literatura académica sobre el tema "Hematological malignancie"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte las listas temáticas de artículos, libros, tesis, actas de conferencias y otras fuentes académicas sobre el tema "Hematological malignancie".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Artículos de revistas sobre el tema "Hematological malignancie"
Miao, Miao, Wu Depei, Aining Sun, Ying Wang, Lingzhi Yan y Qian Wu. "The Efficacy and Safety of Recombinant Human Thrombopoietin in Patients with Hematological Malgnancies After Allogeneic Hematopoietic Stem Cell Transplantation". Blood 118, n.º 21 (18 de noviembre de 2011): 4565. http://dx.doi.org/10.1182/blood.v118.21.4565.4565.
Texto completoDong, L., X.-Y. Zhai, Y.-L. Yang, L. Wang, Y. Zhou, H.-Y. Shi, B.-H. Tang et al. "P110 Population pharmacokinetics and dosing optimisation of imipenem in children with haematological malignancie". Archives of Disease in Childhood 104, n.º 6 (17 de mayo de 2019): e63.3-e63. http://dx.doi.org/10.1136/archdischild-2019-esdppp.148.
Texto completoZinzani, Pier Luigi, Enrico Derenzini, Cinzia Pellegrini, Luigi Rigacci, Alberto Fabbri, Federica Quirini, Vittorio Stefoni et al. "Fludarabine and Mitoxantrone Followed by Yttrium-90 Ibritumumab Tiuxetan in Untreated Patients with Follicular Lymphoma. Long Term Efficacy and Toxicity Results of the FLUMIZ Trial." Blood 118, n.º 21 (18 de noviembre de 2011): 1604. http://dx.doi.org/10.1182/blood.v118.21.1604.1604.
Texto completoClemmensen, Signe B., Jennifer R. Harris, Jonas Mengel-From, Wagner H. Bonat, Henrik Frederiksen, Jaakko Kaprio y Jacob v. B. Hjelmborg. "Familial Risk and Heritability of Hematologic Malignancies in the Nordic Twin Study of Cancer". Cancers 13, n.º 12 (16 de junio de 2021): 3023. http://dx.doi.org/10.3390/cancers13123023.
Texto completoAsare, Mariette, Jeanne E. Hendrickson y Christopher A. Tormey. "Determination of Red Blood Cell Alloimmunization Rates in Transfused Patients with Hematologic and Oncologic Malignancies". Blood 128, n.º 22 (2 de diciembre de 2016): 1463. http://dx.doi.org/10.1182/blood.v128.22.1463.1463.
Texto completoLiao, Yongkang, Shijun Xiong, Zaid Ur Rehman, Xiaoli He, Hongling Peng, Jing Liu y Shuming Sun. "The Research Advances of Aptamers in Hematologic Malignancies". Cancers 15, n.º 1 (1 de enero de 2023): 300. http://dx.doi.org/10.3390/cancers15010300.
Texto completoYang, Xiao-Jing, Ya-Ming Xi y Zi-Jian Li. "Icaritin: A Novel Natural Candidate for Hematological Malignancies Therapy". BioMed Research International 2019 (28 de marzo de 2019): 1–7. http://dx.doi.org/10.1155/2019/4860268.
Texto completoRen, Anqi, Xiqin Tong, Na Xu, Tongcun Zhang, Fuling Zhou y Haichuan Zhu. "CAR T-Cell Immunotherapy Treating T-ALL: Challenges and Opportunities". Vaccines 11, n.º 1 (12 de enero de 2023): 165. http://dx.doi.org/10.3390/vaccines11010165.
Texto completoYAEGASHI, HIROSHI, TAKAHIRO NOHARA, KAZUYOSHI SHIGEHARA, KOUJI IZUMI, YOSHIFUMI KADONO, TOMOYUKI MAKINO, KANAME YAMASHITA, KOUSHIRO OHTSUBO, HIROKO IKEDA y ATSUSHI MIZOKAMI. "Survival Outcomes of Patients With Primary Mediastinal Germ Cell Tumors: A Retrospective Single-institutional Experience". Cancer Diagnosis & Prognosis 2, n.º 3 (3 de mayo de 2022): 352–59. http://dx.doi.org/10.21873/cdp.10116.
Texto completoKrishnan, Gayathri y Anupam Pande. "985. Fusarium Infections in Patients with Hematological Malignancies". Open Forum Infectious Diseases 8, Supplement_1 (1 de noviembre de 2021): S583—S584. http://dx.doi.org/10.1093/ofid/ofab466.1179.
Texto completoTesis sobre el tema "Hematological malignancie"
Akarca, Ayse. "Immunohistochemical studies for identification of biomarkers in haematological malignancies: An approach for potential novel therapeutic targets". Doctoral thesis, Università di Siena, 2021. http://hdl.handle.net/11365/1127626.
Texto completoSchouten, Hendricus Constantinus. "Chromosomal abnormalities in hematological malignancies". Maastricht : Maastricht : Datawyse ; University Library, Maastricht University [Host], 1991. http://arno.unimaas.nl/show.cgi?fid=5640.
Texto completoRunarsson, Gudmundur. "Biosynthesis of leukotriene B₄ in hematological malignancies /". Stockholm, 2005. http://diss.kib.ki.se/2005/91-7140-386-8/.
Texto completoGorkin, David Uscher. "Hematological malignancies: the possible role of BCL11A". Thesis, Boston University, 2004. https://hdl.handle.net/2144/32867.
Texto completoPLEASE NOTE: Boston University Libraries did not receive an Authorization To Manage form for this thesis or dissertation. It is therefore not openly accessible, though it may be available by request. If you are the author or principal advisor of this work and would like to request open access for it, please contact us at open-help@bu.edu. Thank you.
2031-01-01
Buldini, Barbara. "Flow cytometry application in hematological malignancies of childhood". Doctoral thesis, Università degli studi di Padova, 2008. http://hdl.handle.net/11577/3425984.
Texto completoKim, Mee Hye. "Optimisation and application of comparative genomic hybridisation (CGH) in cancer cytogenetics". Thesis, University of Glasgow, 2000. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.272858.
Texto completoCherif, Honar. "Infections in patients with hematological malignancies : etiology, trends and management /". Stockholm, 2005. http://diss.kib.ki.se/2005/91-7140-501-1/.
Texto completoHishizawa, Masakatsu. "Identification of tumor-associated antigens in hematological malignancies by SEREX". Kyoto University, 2006. http://hdl.handle.net/2433/143835.
Texto completoRomano, Alessandra. "High resolution molecular karyotyping and proteomic analysis in hematological malignancies". Thesis, Universita' degli Studi di Catania, 2011. http://hdl.handle.net/10761/96.
Texto completoIn this work we focused on two hematological malignancies to apply the translational meaning of functional genomics: myelodysplastic syndrome (MDS) and its potential evolution to frank acute myeloid leukaemia, and the broad set of monoclonal gammopathies up to multiple myeloma (MM). In both diseases the recent advances obtained thanks to the application of novel therapeutic agents have enlighten the need to target at the same time both neoplastic and surrounding microenvironment cells. In MDS we applied the last generation of Affymetrix single nucleotide polymorphism (SNP)/copy number aberrations (CNA) platform to distinguish somatic and germline tumor-associated CNAs and loss of heterozigosity (LOHs) to identify possible recurring genomic abnormalities in high risk MDS evolving to AML. In particular in one patient, strictly followed in the clinical evolution from MDS to AML, we were able to define the unique features of the aberrant clone through a bioinformatic-based strategy. For MM, we developed ex-vivo assay to identify signalling associated with differential treatments of fresh bone marrow aspirate samples, confirming the unique constellation of activation in the single patient, and the general trend of a differential behavior among neoplastic and surrounding cells. Thanks to a global proteomic technique (RPMA) we identified compensatory pathways potentially responsible of chemoresistance, in both MDS and MM, sustained by the activation of autophagy and pro-survival signalling. In particular, we identified: - Msi-2 as potential biomarker of stemness and aggressivity in MDS, - PLC-y1Tyr783, SrcTyr416 and STAT-5Tyr694 as compensatory pathway responsible of side effects of treatment with azacitidine in MDS, - NFkB status as potential mediator of chemoresistance to dexamethasone in MM, - Akt/mTOR as biomarker of aggressiveness of plasmacells in MM; - an abnormal compartmentalization of serotonin in MM peripheral blood and bone marrow, related to bone disease. Taken together, our data provide potential insights into diagnosis, prognosis, and/or treatment strategies for MDS/AML and MM, through an integrative genomic and proteomic approach.
BANDINI, CECILIA. "FUNCTIONAL GENOMIC APPROACHES TO SENSITIZE HEMATOLOGICAL MALIGNANCIES TO PROTEASOME INHIBITORS". Doctoral thesis, Università degli Studi di Milano, 2020. http://hdl.handle.net/2434/708377.
Texto completoLibros sobre el tema "Hematological malignancie"
Czader, Magdalena, ed. Hematological Malignancies. Totowa, NJ: Humana Press, 2013. http://dx.doi.org/10.1007/978-1-62703-357-2.
Texto completoservice), SpringerLink (Online, ed. Rare Hematological Malignancies. Boston, MA: Springer Science+Business Media, LLC, 2008.
Buscar texto completoAnsell, Stephen M., ed. Rare Hematological Malignancies. Boston, MA: Springer US, 2008. http://dx.doi.org/10.1007/978-0-387-73744-7.
Texto completoFaguet, Guy B. Hematologic Malignancies. New Jersey: Humana Press, 2000. http://dx.doi.org/10.1385/1592590748.
Texto completoHoogstraten, Barth, ed. Hematologic Malignancies. Berlin, Heidelberg: Springer Berlin Heidelberg, 1986. http://dx.doi.org/10.1007/978-3-642-82734-1.
Texto completoBhargava, Manorama. Hematologic Malignancies. Singapore: Springer Singapore, 2021. http://dx.doi.org/10.1007/978-981-33-4799-1.
Texto completoR, Durant J., Hoogstraten B y International Union Against Cancer, eds. Hematologic malignancies. Berlin: Springer, 1986.
Buscar texto completoBarth, Hoogstraten y Durant John R. 1930-, eds. Hematologic malignancies. Berlin: Springer-Verlag, 1986.
Buscar texto completoHentrich, Marcus y Stefan K. Barta, eds. HIV-associated Hematological Malignancies. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-26857-6.
Texto completoOrtolani, Claudio. Flow Cytometry of Hematological Malignancies. Oxford, UK: Blackwell Publishing Ltd., 2011. http://dx.doi.org/10.1002/9781444398069.
Texto completoCapítulos de libros sobre el tema "Hematological malignancie"
Neymark, Niels. "Hematological Malignancies". En Assessing the Economic Value of Anticancer Therapies, 156–82. Berlin, Heidelberg: Springer Berlin Heidelberg, 1998. http://dx.doi.org/10.1007/978-3-642-72123-6_11.
Texto completoGautier, Marc y Harvey Jay Cohen. "Hematologic Malignancies". En Geriatric Medicine, 337–54. New York, NY: Springer New York, 1997. http://dx.doi.org/10.1007/978-1-4757-2705-0_25.
Texto completoGirnius, Andrea, Saulius Girnius y Lesley Gilbertson. "Hematologic Malignancies". En Consults in Obstetric Anesthesiology, 251–54. Cham: Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-59680-8_72.
Texto completoGagnon, Patrick J., Celine Bicquart Ord y Carol Marquez. "Hematologic Malignancies". En Radiation Oncology Study Guide, 325–51. New York, NY: Springer New York, 2013. http://dx.doi.org/10.1007/978-1-4614-6400-6_12.
Texto completoRibera, Josep-Maria. "Second Malignancies". En HIV-associated Hematological Malignancies, 235–37. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-26857-6_21.
Texto completoLamoth, Frédéric. "Epidemiology and Risk Factors of Invasive Fungal Infections". En Hematologic Malignancies, 1–12. Cham: Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-57317-1_1.
Texto completoMatthaiou, Dimitrios K. y George Dimopoulos. "Intensive Care". En Hematologic Malignancies, 147–53. Cham: Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-57317-1_10.
Texto completoBusca, Alessandro, Silvia Corcione y Francesco Giuseppe De Rosa. "Gram-Positive Infections". En Hematologic Malignancies, 155–60. Cham: Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-57317-1_11.
Texto completoBassetti, Matteo, Elda Righi y Murat Akova. "Gram-Negative Infections". En Hematologic Malignancies, 161–79. Cham: Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-57317-1_12.
Texto completoSprute, Rosanne, Philipp Koehler y Oliver A. Cornely. "Herpes Viruses". En Hematologic Malignancies, 181–89. Cham: Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-57317-1_13.
Texto completoActas de conferencias sobre el tema "Hematological malignancie"
Kuttikrishnan, Shilpa, Kirti S. Prabhu, Tamam Elimat, Ashraf Khalil, Nicholas H. Oberlies, Feras Q. Alali y Shahab Uddin. "Anticancer Activity of Neosetophomone B, An Aquatic Fungal Secondary Metabolite, Against Hematological Malignancie S". En Qatar University Annual Research Forum & Exhibition. Qatar University Press, 2021. http://dx.doi.org/10.29117/quarfe.2021.0106.
Texto completo"Nanotechnology for Human Hematological Malignancies Treatment". En International Conference on Biotechnology, Nanotechnology and Environmental Engineering. International Academy of Arts, Science & Technology, 2015. http://dx.doi.org/10.15242/iaast.a0415036.
Texto completoMikami, Yu, Daiya Takai, Masafumi Horie, Satoshi Noguchi, Hirotaka Matsuzaki, Kosuke Makita, Hideyuki Takeshima, Yasuhiro Yamauchi, Go Tanaka y Takahide Nagase. "Respiratory manifestations in hospitalized patients with hematological malignancies". En Annual Congress 2015. European Respiratory Society, 2015. http://dx.doi.org/10.1183/13993003.congress-2015.oa2907.
Texto completoTertemiz, Kemal Can, Aylin Ozgen Alpaydin, Seda Salman y Inci Alacacioglu. "Diagnostic yield of bronchoalveolar lavage in hematological malignancies". En Annual Congress 2015. European Respiratory Society, 2015. http://dx.doi.org/10.1183/13993003.congress-2015.pa2646.
Texto completoHeikkinen, Tuomas, Kati Kämpjärvi, Sirpa Leppä, Peter Hokland, Heikki Kuusanmäki, Satu Mustjoki, Marjatta Sinisalo, Caroline Heckman, Mika Kontro y Pia Vahteristo. "Abstract 1169: Somatic MED12 mutations in hematological malignancies". En Proceedings: AACR 107th Annual Meeting 2016; April 16-20, 2016; New Orleans, LA. American Association for Cancer Research, 2016. http://dx.doi.org/10.1158/1538-7445.am2016-1169.
Texto completoBorgovan, Theo. "Abstract 1016: A new biomarker in hematological malignancies". En Proceedings: AACR Annual Meeting 2021; April 10-15, 2021 and May 17-21, 2021; Philadelphia, PA. American Association for Cancer Research, 2021. http://dx.doi.org/10.1158/1538-7445.am2021-1016.
Texto completoLaklaai, Z., K. Channoune, N. Zaghba, H. Benjelloune y N. Yassine. "Radiological aspects of thoracic involvement in hematological malignancies". En ERS International Congress 2022 abstracts. European Respiratory Society, 2022. http://dx.doi.org/10.1183/13993003.congress-2022.3226.
Texto completo"Study of hematologic malignancy vaccines". En International Conference on Medicine, Public Health and Biological Sciences. CASRP Publishing Company, Ltd. Uk, 2016. http://dx.doi.org/10.18869/mphbs.2016.117.
Texto completoAlbrecht, S., H. Male, H. W. Barkman, V. R. Sethapati y M. T. Cunningham. "Prognosis of Hematologic Malignancies in Pleural Fluid". En American Thoracic Society 2020 International Conference, May 15-20, 2020 - Philadelphia, PA. American Thoracic Society, 2020. http://dx.doi.org/10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a4199.
Texto completoSpicuzza, Lucia, Emanuela Cannata, Lisa Angileri, Giovanna Russo, Andrea Di Cataldo y Nunzio Crimi. "Risk factors for impaired pulmonary function in adult survivors of childhood hematological and non-hematological malignancies". En ERS International Congress 2020 abstracts. European Respiratory Society, 2020. http://dx.doi.org/10.1183/13993003.congress-2020.1664.
Texto completoInformes sobre el tema "Hematological malignancie"
Press, O. W. Improved radioimmunotherapy of hematologic malignancies. Office of Scientific and Technical Information (OSTI), marzo de 1992. http://dx.doi.org/10.2172/5376292.
Texto completoPress, O. W. Improved radioimmunotherapy of hematologic malignancies. [Final report]. Office of Scientific and Technical Information (OSTI), marzo de 1992. http://dx.doi.org/10.2172/10141667.
Texto completoPress, O. W. Improved radioimmunotherapy of hematologic malignancies. Final technical report. Office of Scientific and Technical Information (OSTI), agosto de 1996. http://dx.doi.org/10.2172/373849.
Texto completoPress, O. W. y D. F. Barofsky. Improved radioimmunotherapy of hematologic malignancies. Progress report, 1988--1991. Office of Scientific and Technical Information (OSTI), diciembre de 1991. http://dx.doi.org/10.2172/10112383.
Texto completoLiang, Zuohui, Jie Liu, Hongxia Jin, Yirong Teng, Shuangyan Xu, Weimin Yan y Yun Zhu. Potential correlation between eczema and hematological malignancies risk: a systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, junio de 2022. http://dx.doi.org/10.37766/inplasy2022.6.0097.
Texto completoPress, O. W. Improved radioimmunotherapy of hematologic malignancies. Progress report, November 1, 1993--October 31, 1994. Office of Scientific and Technical Information (OSTI), agosto de 1994. http://dx.doi.org/10.2172/10187100.
Texto completoJi, Conghua, Rongchen Dai, Hanting Wu, Qiushuang Li, Shan Liu, Peijie He, Juan Liang y Qing Guo. Efficacy and safety of hematopoietic stem cell transplantation for hematologic malignancies: A protocol for an overview of systematic reviews and meta-analyses. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, mayo de 2021. http://dx.doi.org/10.37766/inplasy2021.5.0064.
Texto completoZhao, Kangjia, Jiwen Sun, Nanping Shen, Mengxue He, Haishan Ruan, Geng Lin, Jiali Ma y Yanhua Xu. Treatment-Related Adverse Events of Chimeric Antigen receptor T-Cell (CAR-T) Cell Therapy in B-cell hematological malignancies in the Pediatric and Young Adult Population: A Systematic Review and Meta-Analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, julio de 2022. http://dx.doi.org/10.37766/inplasy2022.7.0034.
Texto completo